Manufacturers Life Insurance Company, The Aclaris Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.92 - $1.44 $1,078 - $1,687	-1,172 Reduced 7.34%	14,788 $18,000
Q4 2023 Feb 13, 2024	SELL	$0.64 - $6.49 $7,688 - $77,970	-12,014 Reduced 42.95%	15,960 $16,000
Q3 2023 Nov 15, 2023	BUY	$6.56 - $10.95 $3,325 - $5,551	507 Added 1.85%	27,974 $191,000
Q2 2023 Aug 11, 2023	BUY	$7.89 - $10.64 $20,048 - $27,036	2,541 Added 10.19%	27,467 $284,000
Q4 2022 Aug 11, 2023	BUY	$14.33 - $18.37 $22,053 - $28,271	1,539 Added 6.58%	24,926 $392,000
Q4 2022 Feb 13, 2023	BUY	$14.33 - $18.37 $22,053 - $28,271	1,539 Added 6.58%	24,926 $392,000
Q3 2022 Aug 11, 2023	SELL	$13.07 - $18.22 $5,855 - $8,162	-448 Reduced 1.88%	23,387 $368,000
Q3 2022 Nov 03, 2022	SELL	$13.07 - $18.22 $5,855 - $8,162	-448 Reduced 1.88%	23,387 $368,000
Q2 2022 Aug 11, 2023	BUY	$10.16 - $17.08 $26,822 - $45,091	2,640 Added 12.46%	23,835 $332,000
Q2 2022 Aug 15, 2022	BUY	$10.16 - $17.08 $26,822 - $45,091	2,640 Added 12.46%	23,835 $333,000
Q1 2022 Aug 11, 2023	SELL	$9.74 - $17.92 $36,339 - $66,859	-3,731 Reduced 14.97%	21,195 $365,000
Q1 2022 May 20, 2022	SELL	$9.74 - $17.92 $51,622 - $94,976	-5,300 Reduced 20.0%	21,195 $365,000
Q4 2021 Feb 16, 2022	SELL	$12.27 - $18.49 $1,030 - $1,553	-84 Reduced 0.32%	26,495 $385,000
Q3 2021 Nov 12, 2021	BUY	$13.38 - $18.8 $24,940 - $35,043	1,864 Added 7.54%	26,579 $478,000
Q2 2021 Aug 12, 2021	BUY	$17.08 - $29.6 $422,132 - $731,564	24,715 New	24,715 $434,000
Q2 2019 Aug 14, 2019	SELL	$2.13 - $7.06 $54,564 - $180,856	-25,617 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$5.63 - $7.84 $69,181 - $96,337	12,288 Added 92.19%	25,617 $153,000
Q4 2018 Feb 14, 2019	BUY	$6.3 - $15.4 $16,978 - $41,503	2,695 Added 25.34%	13,329 $99,000
Q3 2018 Nov 14, 2018	SELL	$14.38 - $20.89 $149,077 - $216,566	-10,367 Reduced 49.36%	10,634 $154,000
Q2 2018 Aug 14, 2018	BUY	$16.46 - $20.33 $47,174 - $58,265	2,866 Added 15.8%	21,001 $420,000
Q1 2018 May 15, 2018	SELL	$17.08 - $25.64 $3,381 - $5,076	-198 Reduced 1.08%	18,135 $317,000
Q4 2017 Feb 08, 2018	BUY	$21.47 - $27.8 $15,565 - $20,155	725 Added 4.12%	18,333 $452,000
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $405,336 - $507,110	17,608	17,608 $455,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$41.3 Million
9.64% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$13.6 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.37M
Shares

$9.78 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.01M
Shares

$8.72 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$7.99 Million
0.11% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account